51 results
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
professionals and entities.
The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare … , capital, services and labor within the EU, or single market, and the wider commercial, legal and regulatory environment, will impact our current
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
16 Nov 23
Current report (foreign)
7:01am
and the environment in which each will operate in the future. Past performance is not a guarantee of future performance. Investors should not place undue
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
are based on numerous assumptions regarding the present and future business strategies of such persons and the environment in which each will operate … )
transformational changes in the regulatory environment in the United States and European Union. Neither of these “replacement” directors is qualified to serve
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
and the broader operating environment. These programs have already delivered encouraging clinical results with multiple value-driving milestones ahead
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
18 Oct 22
Mereo BioPharma Announces Updated Operating Plan to Maximize Shareholder Value
7:07am
into account the evolution of our programs, the current business and market environment and ongoing discussions with shareholders,” said Michael Wyzga, Chair
F-3
EX-1.2
9c7 ir9qm
5 Aug 21
Shelf registration (foreign)
4:33pm
6-K
EX-99.1
hztqhg9
16 Apr 21
Current report (foreign)
4:10pm
6-K
EX-1.1
yqzxqhia
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
424B5
127uoqo0xrmg0q slgx
10 Feb 21
Prospectus supplement for primary offering
4:53pm